Intensity Therapeutics, Inc. (INTS)

NASDAQ: INTS · IEX Real-Time Price · USD

4.750

-0.100 (-2.06%)

At close: Jul 19, 2024, 4:30 PM

4.720

-0.030 (-0.63%)

Pre-market: Jul 20, 2024, 9:29 AM EDT

Intensity Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-13.8	-11.86	-7.58	-7.9	-6.03	-5.38
Depreciation & Amortization	0.05	0.15	0.18	0.17	0.12	0.1
Share-Based Compensation	2.24	1.4	1.17	0.72	0.56	0.56
Other Operating Activities	0.84	1.79	0.76	0.18	-0.01	0.31
Operating Cash Flow	-10.67	-7.21	-5.48	-6.83	-5.37	-4.42
Change in Investments	-2.76	-6.02	0	0	4.56	1.7
Investing Cash Flow	-2.76	-6.02	0	0	4.56	1.7
Share Issuance / Repurchase	22.48	22.48	0	0	0	0
Debt Issued / Paid	0.03	0.23	2.25	2.05	0.03	0
Other Financing Activities	-2.23	-2.23	-	-	6.27	3.86
Financing Cash Flow	20.28	20.47	2.25	2.05	6.29	3.86
Net Cash Flow	6.84	7.24	-3.23	-4.78	5.49	1.14
Free Cash Flow	-10.67	-7.21	-5.48	-6.83	-5.37	-4.42
Free Cash Flow Per Share	-0.78	-0.84	-1.61	-2.00	-1.57	-1.30

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).